The Early Treatment for Retinopathy of Prematurity Study (ETROP)
1 other identifier
interventional
N/A
1 country
26
Brief Summary
The goal of the Early Treatment for Retinopathy of Prematurity Study (ETROP) is to test the hypothesis that earlier treatment in carefully selected cases will result in an overall better visual outcome than treatment at the conventional CRYO-ROP threshold point in the disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
26 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2001
CompletedFirst Posted
Study publicly available on registry
October 29, 2001
CompletedFirst Submitted
Initial submission to the registry
November 28, 2001
CompletedJune 24, 2005
December 1, 2003
November 28, 2001
June 23, 2005
Conditions
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (26)
Stanford University School of Medicine
Palo Alto, California, 94304, United States
Smith-Kettlewell Eye Research Institute
San Francisco, California, 94115-1813, United States
UIC Eye Center Department of Ophthalmology and Visual Sciences The Lions of Illinois Eye Research Institute
Chicago, Illinois, 60612-724, United States
Indiana University Department of Pediatrics
Indianapolis, Indiana, 46002-2119, United States
University of Louisville Health Sciences Center
Louisville, Kentucky, 40202-1594, United States
Tulane University Medical Center
New Orleans, Louisiana, 70112-2699, United States
University of Maryland School of Medicine
Baltimore, Maryland, 21201-1595, United States
The Zanvyl Krieger Children's Eye Center
Baltimore, Maryland, 21287, United States
Tufts University School of Medicine Department of Pediatrics
Boston, Massachusetts, 02111, United States
Pediatric Ophthalmology Associates, PC
Dearborn, Michigan, 48124, United States
University of Minnesota
Minneapolis, Minnesota, 55455-0591, United States
Cardinal Glennon Children's Hospital Neonatology Office
St Louis, Missouri, 63104, United States
The Children's Hospital of Buffalo Department of Ophthalmology
Buffalo, New York, 14222-2099, United States
Edward S. Harkness Eye Institute
New York, New York, 10032, United States
University of Rochester Medical Center
Rochester, New York, 14642, United States
Eastern Long Island Retina Associate
Shirley, New York, 111967, United States
Duke University Eye Center
Durham, North Carolina, 27710, United States
Columbus Children's Hospital
Columbus, Ohio, 43205, United States
The Dean A. McGee Eye Institute
Oklahoma City, Oklahoma, 73104, United States
Oregon Health Sciences University Casey Eye Institute
Portland, Oregon, 97201-4197, United States
The Children's Hospital of Philadelphia Division of Pediatric Ophthalmology
Philadelphia, Pennsylvania, 19104-4399, United States
Magee-Women's Hospital
Pittsburgh, Pennsylvania, 15213-3180, United States
Medical University of South Carolina
Charleston, South Carolina, 29425-2236, United States
Baylor College of Medicine Feigin Center
Houston, Texas, 77030, United States
University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78229-3900, United States
John Moran Eye Center University of Utah Health Sciences Center
Salt Lake City, Utah, United States
Related Publications (7)
Wallace DK, Bremer DL, Good WV, Fellows R, Summers CG, Tung B, Hardy RJ. Correlation of recognition visual acuity with posterior retinal structure in advanced retinopathy of prematurity. Arch Ophthalmol. 2012 Dec;130(12):1512-6. doi: 10.1001/archophthalmol.2012.2118.
PMID: 22892757DERIVEDGood WV, Hardy RJ, Wallace DK, Bremer D, Rogers DL, Siatkowski RM, De Becker I, Summers CG, Fellows R, Tung B, Palmer EA. beta-Blocking and racial variation in the severity of retinopathy of prematurity. Arch Ophthalmol. 2012 Jan;130(1):117-8. doi: 10.1001/archopht.130.1.117. No abstract available.
PMID: 22232483DERIVEDVanderVeen DK, Bremer DL, Fellows RR, Hardy RJ, Neely DE, Palmer EA, Rogers DL, Tung B, Good WV; Early Treatment for Retinopathy of Prematurity Cooperative Group. Prevalence and course of strabismus through age 6 years in participants of the Early Treatment for Retinopathy of Prematurity randomized trial. J AAPOS. 2011 Dec;15(6):536-40. doi: 10.1016/j.jaapos.2011.07.017.
PMID: 22153396DERIVEDEarly Treatment for Retinopathy of Prematurity Cooperative Group; Dobson V, Quinn GE, Summers CG, Hardy RJ, Tung B, Good WV. Grating visual acuity results in the early treatment for retinopathy of prematurity study. Arch Ophthalmol. 2011 Jul;129(7):840-6. doi: 10.1001/archophthalmol.2011.143.
PMID: 21746974DERIVEDQuinn GE, Dobson V, Hardy RJ, Tung B, Palmer EA, Good WV; Early Treatment for Retinopathy of Prematurity Cooperative Group. Visual field extent at 6 years of age in children who had high-risk prethreshold retinopathy of prematurity. Arch Ophthalmol. 2011 Feb;129(2):127-32. doi: 10.1001/archophthalmol.2010.360.
PMID: 21320954DERIVEDChristiansen SP, Dobson V, Quinn GE, Good WV, Tung B, Hardy RJ, Baker JD, Hoffman RO, Reynolds JD, Rychwalski PJ, Shapiro MJ; Early Treatment for Retinopathy of Prematurity Cooperative Group. Progression of type 2 to type 1 retinopathy of prematurity in the Early Treatment for Retinopathy of Prematurity Study. Arch Ophthalmol. 2010 Apr;128(4):461-5. doi: 10.1001/archophthalmol.2010.34.
PMID: 20385942DERIVEDEarly Treatment for Retinopathy of Prematurity Cooperative Group; Good WV, Hardy RJ, Dobson V, Palmer EA, Phelps DL, Tung B, Redford M. Final visual acuity results in the early treatment for retinopathy of prematurity study. Arch Ophthalmol. 2010 Jun;128(6):663-71. doi: 10.1001/archophthalmol.2010.72. Epub 2010 Apr 12.
PMID: 20385926DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
William V. Good, M.D.
Smith-Kettlewell Eye Research Institute
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Purpose
- TREATMENT
- Sponsor Type
- NIH
Study Record Dates
First Submitted
November 28, 2001
First Posted
October 29, 2001
Study Start
October 1, 2001
Last Updated
June 24, 2005
Record last verified: 2003-12